Back to search
FDAFDA · Food and drugs·Recall number D-1360-2015

Bactroban Ointment (mupirocin calcium), 2% 22g tube ,Rx only, Manufactured by Glaxo Operations UK Ltd, Harmire Road, Barnard Castle, UK for GlaxoSmithKline PO Box 1217 Zebulon, NC 27597-1217. NDC 0029-1525-44

Published September 2, 2015 · Recall initiated: August 13, 2015

Summary

FDA records drug Class II recall D-1360-2015, published September 2, 2015 and initiated August 13, 2015. Recalling firm: GlaxoSmithKline, LLC.; Status: Terminated; Reported quantity: 19,520 tubes; Lot: Lot #: C698039, Exp 03/2016. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Penicillin Cross Contamination and Presence of Foreign Substance. Product was contaminated with penicillin and foreign substances during manufacturing process.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
GlaxoSmithKline, LLC.
Distributor
Nationwide and Puerto Rico
Lot
Lot #: C698039, Exp 03/2016
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Bactroban Ointment (mupirocin calcium), 2% 22g tube ,Rx only, Manufactured by Glaxo Operations UK Ltd, Harmire Road, Barnard Castle, UK for GlaxoSmithKline PO Box 1217 Zebulon, NC 27597-1217. NDC 0029-1525-44 recalled?

Yes. FDA published recall D-1360-2015 on September 2, 2015. Reported hazard: Penicillin Cross Contamination and Presence of Foreign Substance. Product was contaminated with penicillin and foreign substances during manufacturing process.

What should I do if I have this product?

Voluntary: Firm initiated · Letter